UnitedHealth Group Incorporated (NYSE:UNH) Stake Lowered by Tranquility Partners LLC

Tranquility Partners LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 9,447 shares of the healthcare conglomerate’s stock after selling 956 shares during the period. UnitedHealth Group accounts for 2.1% of Tranquility Partners LLC’s investment portfolio, making the stock its 6th largest holding. Tranquility Partners LLC’s holdings in UnitedHealth Group were worth $4,974,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $26,000. Robbins Farley purchased a new stake in UnitedHealth Group during the third quarter valued at approximately $25,000. CGC Financial Services LLC raised its position in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the period. NewSquare Capital LLC raised its position in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA raised its position in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Piper Sandler upped their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. Wells Fargo & Company cut their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Three equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $571.20.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Up 2.2 %

NYSE UNH traded up $10.10 during midday trading on Wednesday, hitting $478.99. 8,753,188 shares of the company traded hands, compared to its average volume of 4,466,714. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The company has a market cap of $441.60 billion, a PE ratio of 20.09, a price-to-earnings-growth ratio of 1.22 and a beta of 0.54. The company’s 50-day simple moving average is $490.31 and its 200-day simple moving average is $515.63. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the business posted $6.26 EPS. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.57%. UnitedHealth Group’s dividend payout ratio is presently 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.